Court Rules Against Inmates Challenging Tennessee Department of Corrections Hepatitis C Protocol
Court Finds TDOC鈥檚 Past Hepatitis C Protocol 鈥淏ordered on Deliberate Indifference鈥
NASHVILLE 鈥 A federal court ruled late yesterday against inmates who were denied adequate medical care after being diagnosed with Hepatitis C (HCV) while under the supervision of the Tennessee Department of Corrections (TDOC). The lawsuit was filed by the 老澳门开奖结果 of Tennessee, Disability Rights Tennessee and Branstetter, Stranch & Jennings, PLLC on behalf of inmates who were denied adequate medical care after being diagnosed with HCV.
The federal class action lawsuit was filed in July of 2016. At the time of the filing, a nationwide medically accepted standard of care for HCV using direct-acting anti-viral drugs (DAA) was established that resulted in curing the disease in at least 90 percent of cases. However, as of May 2016, only eight of the 3,487 Tennessee Department of Corrections inmates identified as infected were receiving treatment with direct-acting anti-viral drugs. TDOC further acknowledged that nearly half of the inmates tested for Hepatitis C in 2015 were positive, which puts the likely number of infected inmates closer to 10,000.
In the words of the court, the inmates who testified at the trial 鈥減resented compelling proof鈥 that 鈥淭DOC鈥檚 treatment of HCV inmates has been erratic, uneven, and poor, resulting in denial of DAA treatment where it was clearly appropriate. There is convincing evidence that TDOC鈥檚 DAA past treatment protocols have been uneven, and have bordered on deliberate indifference to serious medical needs of individual inmates.鈥
At least 109 inmates have died from complications related to HCV in Tennessee Department of Corrections custody since 2009.
In 2019, about two months before the trial and over three years after the lawsuit was filed, the Tennessee Department of Corrections put in place new HCV policies and protocols. The court鈥檚 decision was based on these new policies.
The judge concludes, 鈥淭ime will tell whether TDOC implements the 2019 HCV Guidance in the dedicated manner it has represented and continues to accelerate approval of inmates for treatment with DAAs. It would behoove TDOC to do so and to engage [the plaintiff鈥檚 expert witness] to assist in maintaining this progress, lest treatment that is not grossly inadequate today be subject to that renewed claim in the future."
The following reaction is from:
Hedy Weinberg, 老澳门开奖结果 of Tennessee executive director: 鈥淲hile we are troubled by the court鈥檚 decision, we are gratified that our lawsuit forced the Tennessee Department of Corrections to change its Hepatitis C treatment policies. However, for far too many years, thousands of inmates never received appropriate treatment 鈥 suffering needlessly from a permanently damaging and entirely preventable disease. We will continue to remain vigilant and monitor to ensure that the state implements its new protocol in a committed manner.鈥
Sherry A. Wilds, Disability Rights Tennessee director of pro bono services & legal interns/senior staff attorney: 鈥淟et us not forget those Tennesseans behind locked doors, hidden from view. It is our hope that the Tennessee Department of Corrections will ensure these individuals receive this necessary treatment in a timely manner despite this ruling. It is the right thing to do and we will continue to push this important issue.鈥
老澳门开奖结果-TN cooperating attorney Karla Campbell of Branstetter, Stranch & Jennings, PLLC: 鈥淲hile we disagree with the court鈥檚 decision, we note that it was based on a new Hepatitis C treatment policy that the department adopted approximately two months before trial. However, prior to that, more than 100 inmates died from complications of the disease because of the department鈥檚 failure to adequately treat them. We regret that so many had to suffer so much before the department changed its policies, but we are proud to have been the catalyst for that change.鈥
The court鈥檚 decision can be found at:
More information on this case can be found at: